Expert Opinion on Therapeutic Patents
Taylor and Francis Ltd. · England
Metrics
- Impact factor
- 4.7+0.1 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 1.098Q1 SCImago
- h-index
- 61
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Citations per paper
- 4.92 last 2 years
- Articles per year
- 66
- Self-citation
- 1.9%
- Fee (APC), est.
- $3,437 estimated, check the journal
About this journal
- ISSN
- 1354-3776 (print) · 1744-7674 (online)
- Publisher
- Taylor and Francis Ltd. · Taylor & Francis
- Country
- England · Western Europe
- Indexed in
- SCIE
- Access
- Hybrid · 3% gold OA
- Founded
- 1994
- Frequency
- Monthly
- Original research
- 16.3%
- Subject areas
- Medicine, Pharmacology, Toxicology and Pharmaceutics
- Categories
- Medicine, Pharmacy
- Common topics
- Biology, Medicine, Chemistry, Biochemistry, Genetics
Similar journals
- Q1WoS
New England Journal of Medicine
Impact factor 84.5h-index 933SJR 18.40 - Q1WoS
Lancet
Impact factor 109h-index 700SJR 14.82 - Q1WoS
Jama-Journal of the American Medical Association
Impact factor 65.4h-index 622SJR 5.84 - Q1WoS
Circulation
Impact factor 41.3h-index 570SJR 8.31 - Q1WoS
Bmj-British Medical Journal
Impact factor 55.1h-index 543SJR 1.99 - Q1WoS
Nature Medicine
Impact factor 52.5h-index 497SJR 17.50
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals